| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 9e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |